Funding

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Funder
National Institutes of Health
Programme
PAR-25-282
Opportunity type
Research funding opportunity
Call status
Closed
Opens
2025-01-16
Deadline
2026-10-16
View opportunity

Overview

Supports exploratory translational research into mood and psychotic symptoms during the menopause transition. Projects should examine underlying mechanisms and identify promising targets for future intervention development.

Funding amount

Up to USD 275,000 in direct costs over 2 years; maximum USD 200,000 per year

Eligibility

Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.

Additional deadlines

Next new-application deadline: 16 October 2026. Next renewal/resubmission/revision deadline, where permitted: 16 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2028. This is separate from the application deadline.

Official source
NIH / Grants.gov
Last checked
2026-09-19